From Medscape Diabetes & Endocrinology

Coverage from the

American Diabetes Association (ADA) 76th Scientific Sessions

June 10 - 14, 2016; New Orleans, Louisiana

June 10 - 14, 2016 New Orleans, Louisiana

Medscape booth #661

Meeting Highlights at a Glance

Conference News

News At A Glance

Most Popular News from ADA 2015

Medscape Diabetes©  WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Live Blog

Medscape Board at the Podium

  • Per-Henrik Groop, MD
    Helsinki University Central Hospital, Finland
    Presentation: Excess CVD Morbidity in Type 1 Diabetes According to Nephropathy and Kidney Function
    Date: June 11, 2016
    Presentation: Effects of Linagliptin on Glycemic Control and Albuminuria in Type 2 Diabetes-The MARLINA-T2D Trial
    Date: June 12, 2016
    Presentation: Metabolic Subtypes of Type 1 Diabetes, Medication Costs, and Progression of Diabetic Kidney Disease during 14 Years of Follow-Up
    Date: June 12, 2016
    Presentation: Pedigree-based Analysis of Diabetic Nephropathy in T1D Patients
    Date: June 12, 2016
  • Vivian Fonseca, MD
    Tulane University, New Orleans, Louisiana
    Presentation: The Effect of Metformin Exposure on Neurodegenerative Disease among Elder Adult Veterans with Diabetes Mellitus
    Date: June 11, 2016
    Presentation: Linagliptin Modulates Intra-islet GLP-1 vs. Glucagon Secretion and Production
    Date: June 12, 2016
    Presentation: Life-Course Interaction between Fasting Blood Glucose and Body Mass Index Affects Mid-adulthood Physical Performance
    Date: June 12, 2016
    Presentation: Birth Weight and Cardiometabolic Risk in Children: The National Health and Nutrition Examination Survey (NHANES), 1999-2014
    Date: June 12, 2016
    Presentation: Metformin Exposure Is Associated with Diabetic Neuropathy
    Date: June 13, 2016
  • Anne Peters, MD
    University of Southern California at Los Angeles
    Presentation: HbA1c Knowledge in Adults with Type 1 Diabetes: Does Patient Accuracy Matter?
    Date: June 11, 2016
    Presentation: Impact of Intensive Lifestyle Intervention on the Compression of Lifetime Disability: The Look AHEAD Trial
    Date: June 11, 2016
    Presentation: Improved Treatment Satisfaction in People with Type 1 Diabetes Mellitus (T1DM) Treated with Canagliflozin (CANA)
    Date: June 12, 2016
    Presentation: Canagliflozin (CANA) Improves Glycemic Control and Reduces Glycemic Variability in Patients with Type 1 Diabetes Mellitus (T1DM) Inadequately Controlled with Insulin
    Date: June 13, 2016
  • Arya Sharma, MD, PhD
    University of Alberta; Royal Alexandra Hospital, Weight Wise Clinic, Edmonton, Alberta
    Presentation: Drug Interventions
    Date: June 12, 2016